A New Year Filled With Debate Over Drug Pricing, PwC Predicts
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug pricing and M&A top PwC’s Health Research Institute annual report highlighting the top issues impacting the health care sector in the year ahead.